Inadvertent anticoagulation of a haemophiliac child with routine line flushing

Haemophilia

Volumn 12, Issue 5, 2006, Pages 548-550

  Lambert, C ^a   Deneys, V ^a   Pothen, D ^a   Vermylen, C ^a   Hermans, C ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Central venous access device; Haemophilia; Heparin

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8; HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; SODIUM CHLORIDE;

ANEMIA; ANTICOAGULATION; ANUS ATRESIA; ARTICLE; BLEEDING; BLOOD CELL COUNT; CASE REPORT; CONTINUOUS INFUSION; DEVICE INFECTION; DISEASE SEVERITY; DRUG MEGADOSE; ESOPHAGUS ATRESIA; HEMARTHROSIS; HEMOPHILIA A; HUMAN; KIDNEY MALFORMATION; MALE; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY ARTERY STENOSIS; RECURRENT DISEASE; SPINE MALFORMATION; SYMPTOM; SYNDROME VATER; THROMBOELASTOGRAPHY; VASCULAR ACCESS DEVICE; VASCULAR PATENCY;

ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CHILD, PRESCHOOL; HEMARTHROSIS; HEMOPHILIA A; HEPARIN; HUMANS; MALE; RECURRENCE; THROMBIN TIME;

EID: 33747186400     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2006.01294.x     Document Type: Article

References (15)

1. Ewenstein BM, Valentino LA, Journeycake JM et al. Consensus recommendations for use of central venous access devices in haemophilia. Haemophilia 2004; 10: 629-48.
2. Journeycake JM, Buchanan GR. Thrombotic complications of central venous catheters in children. Curr Opin Hematol 2003; 10: 369-74.
3. Domm JA, Hudson MG, Janco RL. Complications of central venous access devices in paediatric haemophilia patients. Haemophilia 2003; 9: 50-6.
4. Valentino LA, Ewenstein B, Navickis Rj, Wilkes MM. Central venous access devices in haemophilia. Haemophilia 2004; 10: 134.
5. McMahon C, Smith J, Khair K, Liesner R, Hann MI, Smith OP. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome. Br J Haematol 2000; 110: 461-8.
6. MASAC. MASAC recommendations regarding central venous access devices included ports and passports. MASAC, 2001. Available at: http://www.hemophilia.org/research/masac/masac115.htm; accessed June 8, 2004.
7. Van den Berg HM, Fischer K, Roosendaal G, Mauser-Bunschoten EP. The use of the Port-A-Cath in children with haemophilia - a review. Haemophilia 1998; 4: 418-20.
8. Rao S, Alladi A, Das K, Cruz AJD. Medium- and long-term central venous access in children. Indian Pediatr 2003; 40: 41-4.
9. Santagostino E, Gringeri A, Muca-Perja M, Mannucci PM. A prospective clinical trial of implantable central venous access in children with haemophilia. Br J Haematol 1998; 102: 1224-8.
10. Ljung R, van den Berg M, Petrini P et al. Port-A-Cath usage in children with haemophilia: Experience of 53 cases. Acta Paediatr 1998; 87: 1051-4.
11. Liesner RJ, Vora AJ, Hann IM, Lilleymann JS. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995; 91: 203-7.
12. Smith S, Dawson S, Hennessey R, Andrew M. Maintenance of the patency of indwelling central venous catheters: Is heparine necessary? Am J Pediatr Hematol Oncol 1991; 13: 141-3.
13. Vidler V, Richards M, Vora A. Central venous catheter-associated thrombosis in severe haemophilia. Br J Haematol 1999; 104: 461-4.
14. Moritz ML, Vats A, Ellis D. Systemic anticoagulation and bleeding in children with hemodialysis catheters. Pediatr Nephrol 2003; 18: 68-70.
15. LeDuc K. Efficacy of normal saline solution versus heparin solution for maintaining patency of peripheral intravenous catheters in children. J Emerg Nurs 1997; 23: 306-9.